Ariosa Diagnostics, Inc. is a global molecular diagnostics company committed to improving overall patient care by developing and delivering innovative, affordable, and widely-accessible testing services through its CLIA laboratory. Tests are fully validated to CLIA requirements by rigorous and comprehensive methodologies to ensure healthcare practitioners and patients can be confident in the test’s performance. Ariosa has developed the technologies to perform a directed analysis of cell-free DNA in blood.
San Jose, US
Size (employees)
101 (est)
Ariosa Diagnostics was founded in 2009 and is headquartered in San Jose, US
Report incorrect company information

Ariosa Diagnostics Office Locations

Ariosa Diagnostics has an office in San Jose
San Jose, US (HQ)
5945 Optical Court
Show all (1)
Report incorrect company information

Ariosa Diagnostics Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$67.5 m

Latest funding size

$52.70 m

Time since last funding

6 years ago


Ariosa Diagnostics's latest funding round in January 2012 was reported to be $52.7 m. In total, Ariosa Diagnostics has raised $67.5 m
Show all financial metrics
Report incorrect company information